Literature DB >> 25522307

GWAS-Identified Common Variants With Nonalcoholic Fatty Liver Disease in Chinese Children.

Xiao-Rui Shang1, Jie-Yun Song, Fang-Hong Liu, Jun Ma, Hai-Jun Wang.   

Abstract

OBJECTIVES: Three genome-wide association studies were previously done for nonalcoholic fatty liver disease (NAFLD) among individuals of Western countries and identified several genetic variants associated with NAFLD. The study aimed to identify whether 7 GWAS-identified common variants (GCKR rs780094, PDGFA rs343064, FDFT1 rs2645424, COL13A1 rs1227756, EHBP1L1 rs6591182, NCAN rs2228603, and PNPLA3 rs738409) were associated with NAFLD in Chinese children.
METHODS: This case-control study recruited 1027 Chinese children of age 7 to 18 years, including 162 children with NAFLD and 865 children without NAFLD. Anthropometric measurements, alanine transaminase (ALT) detection, liver ultrasound examination, and genotyping of 7 variants were performed.
RESULTS: The G-allele of PNPLA3 rs738409 was associated with NAFLD (odds ratio [OR] 1.55, 95% confidence interval 1.13-2.11, P = 0.006) and moderate-to-severe steatosis (OR 3.77, 95% confidence interval 1.78-7.98, P = 0.001) adjusted for age, sex, and BMI standard deviation score. In addition, we found each G-allele of rs738409 increased ALT level by 1.09 IU/L (P = 0.011). Subjects carrying 10 or more risk alleles of 7 variants had an OR of 4.76 (P = 0.025) for NAFLD compared with subjects carrying 3 or fewer risk alleles.
CONCLUSIONS: The PNPLA3 rs738409 G-allele was associated with NAFLD and ALT level in Chinese children. It had stronger association with moderate-to-severe steatosis. Children carrying 10 or more risk alleles of 7 variants were susceptible for NAFLD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25522307     DOI: 10.1097/MPG.0000000000000662

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  11 in total

1.  Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.

Authors:  Elena Larrieta-Carrasco; Yvonne N Flores; Luis R Macías-Kauffer; Paula Ramírez-Palacios; Manuel Quiterio; Eric G Ramírez-Salazar; Paola León-Mimila; Berenice Rivera-Paredez; Guillermo Cabrera-Álvarez; Samuel Canizales-Quinteros; Zuo-Feng Zhang; Tania V López-Pérez; Jorge Salmerón; Rafael Velázquez-Cruz
Journal:  Exp Mol Pathol       Date:  2018-01-04       Impact factor: 3.362

2.  A small supernumerary marker chromosome resulting in mosaic partial tetrasomy 4q26-q31.21 in a foetus with multiple congenital malformations.

Authors:  Zhi-Tao Zhang; Wen-Xu Qi; Cai-Xia Liu; Shao-Wei Yin; Yan Zhao; Jesse Li-Ling; Yuan Lv
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

3.  Role of NCAN rs2228603 polymorphism in the incidence of nonalcoholic fatty liver disease: a case-control study.

Authors:  Meng-Juan Wu; Chen Yuan; Lin-Lin Lu; Bai-Quan An; Shi-Ying Xuan; Yong-Ning Xin
Journal:  Lipids Health Dis       Date:  2016-11-26       Impact factor: 3.876

4.  Physical activity and sedentary behavior can modulate the effect of the PNPLA3 variant on childhood NAFLD: a case-control study in a Chinese population.

Authors:  Shuo Wang; Jieyun Song; Xiaorui Shang; Nitesh Chawla; Yide Yang; Xiangrui Meng; Haijun Wang; Jun Ma
Journal:  BMC Med Genet       Date:  2016-12-01       Impact factor: 2.103

5.  Association of MTTP gene variants with pediatric NAFLD: A candidate-gene-based analysis of single nucleotide variations in obese children.

Authors:  Dongling Dai; Feiqiu Wen; Shaoming Zhou; Zhe Su; Guosheng Liu; Mingbang Wang; Jianli Zhou; Fusheng He
Journal:  PLoS One       Date:  2017-09-27       Impact factor: 3.240

Review 6.  TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease.

Authors:  Li-Zhen Chen; Harry Hua-Xiang Xia; Yong-Ning Xin; Zhong-Hua Lin; Shi-Ying Xuan
Journal:  J Clin Transl Hepatol       Date:  2015-12-15

Review 7.  A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence.

Authors:  Jonathan L Temple; Paul Cordero; Jiawei Li; Vi Nguyen; Jude A Oben
Journal:  Int J Mol Sci       Date:  2016-06-15       Impact factor: 5.923

8.  PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.

Authors:  Gemma Aragonès; Teresa Auguet; Sandra Armengol; Alba Berlanga; Esther Guiu-Jurado; Carmen Aguilar; Salomé Martínez; Fátima Sabench; José Antonio Porras; Maikel Daniel Ruiz; Mercé Hernández; Joan Josep Sirvent; Daniel Del Castillo; Cristóbal Richart
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923

9.  Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis.

Authors:  Ningjian Wang; Chi Chen; Li Zhao; Yi Chen; Bing Han; Fangzhen Xia; Jing Cheng; Qin Li; Yingli Lu
Journal:  EBioMedicine       Date:  2018-01-09       Impact factor: 8.143

10.  Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Nader Salari; Niloufar Darvishi; Kamran Mansouri; Hooman Ghasemi; Melika Hosseinian-Far; Fateme Darvishi; Masoud Mohammadi
Journal:  BMC Endocr Disord       Date:  2021-06-19       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.